UroNurse

UroNurse
  • 5.0 (6)
  • Medicine
  • Updated Weekly

UroNurse is a one hour podcast connecting healthcare workers to urology expert panelists. You can check out our videos and live webinars at uronurse.com. Our podcasts provide an audio copy for you to enjoy in your car or wherever.

  1. 10h ago

    (Audio) BPH Treatment Options in 2026: Is Optilume a Game Changer?

    What are the best treatment options for benign prostatic hyperplasia (BPH) in 2026? And where does the innovative Optilume BPH Catheter System fit into the growing range of treatments available for men with an enlarged prostate? In this episode of UroNurse, host Vic Senese, RN, BSN, FAUNA, is joined by BPH expert Dean Elterman, MD, for an in-depth discussion about the evolving treatment landscape for BPH and lower urinary tract symptoms. BPH is one of the most common conditions affecting aging men and can cause urinary frequency, urgency, weak urinary stream, difficulty starting urination, incomplete bladder emptying, and nighttime urination. While medications such as alpha blockers and 5-alpha-reductase inhibitors remain important treatment options, today's patients have more choices than ever—including minimally invasive procedures and surgical therapies. In this discussion, we'll explore Optilume for BPH, how the technology works, which patients may be candidates, and how it compares with other contemporary BPH treatment options. We'll also discuss: • What is BPH and why does the prostate enlarge with age?• Common symptoms of an enlarged prostate• When medications may be appropriate• Alpha blockers and 5-alpha-reductase inhibitors• Phosphodiesterase-5 inhibitors such as tadalafil• Minimally invasive treatments for BPH• How the Optilume BPH procedure works• Potential benefits and limitations of Optilume• UroLift and other minimally invasive options• Rezūm water vapor therapy• Aquablation therapy• HoLEP and other laser procedures• TURP and traditional surgical treatment• How prostate size and anatomy influence treatment selection• Preserving sexual function and ejaculation when choosing a BPH procedure• Recovery, durability, and patient expectations• How physicians and patients can approach shared decision-making• What men should ask their urologist before choosing a BPH treatment OPTILUME FOR BPH Optilume represents an important development in minimally invasive BPH treatment. The technology combines mechanical dilation with delivery of the drug paclitaxel to the prostatic urethra. We'll discuss what that means for patients and how this approach fits into the broader BPH treatment landscape. WHICH BPH TREATMENT IS RIGHT FOR YOU? There is no single best BPH treatment for every man. The right choice can depend on prostate size, prostate anatomy, symptom severity, urinary retention, medications, bladder function, overall health, and the importance of preserving sexual and ejaculatory function. That's why understanding the differences between Optilume, UroLift, Rezūm, Aquablation, HoLEP, TURP, medications, and other BPH treatments is so important. Join Vic Senese, RN, BSN, FAUNA, and Dean Elterman, MD, as they examine where BPH treatment is heading and what today's patients should know before making a treatment decision. The expert's opinions in this communication are personal and not representative of any organization. They are for informational purposes only, not official guidance. Viewers are advised to use their judgment, seek additional advice, and take responsibility for any actions based on these opinions.

  2. Sep 26

    Audio: Tadalafil Explained: More Than Just an ED Medication

    Tadalafil: What Does It Treat Besides Erectile Dysfunction? When most people hear tadalafil, they think of erectile dysfunction—or ED. But tadalafil is used for more than helping with erections. In this episode of UroNurse News, host Vic Senese, RN, BSN, FAUNA, is joined by co-host Laurie Atkinson, RN, FAUNA, to explain the important medical uses of tadalafil and why this medication may be prescribed for conditions beyond sexual performance. Tadalafil is a PDE5 inhibitor that can affect blood flow and smooth muscle in different parts of the body. Depending on the dose and indication, tadalafil may be used to treat erectile dysfunction (ED), benign prostatic hyperplasia (BPH)and the urinary symptoms associated with an enlarged prostate. It is also approved for pulmonary arterial hypertension (PAH) under specific dosing and medical supervision. In this episode, Vic and Laurie discuss: • What tadalafil is and how it works• Tadalafil for erectile dysfunction• Tadalafil for benign prostatic hyperplasia (BPH)• How tadalafil may improve urinary symptoms associated with an enlarged prostate• Tadalafil and pulmonary arterial hypertension (PAH)• Why tadalafil can have effects beyond erections• Common side effects and important precautions• Why tadalafil should not be combined with nitrates• Why patients should discuss medications and health conditions with their healthcare professional• The difference between tadalafil dosing for different medical conditions If you've been prescribed Cialis or tadalafil and want to understand why, this episode provides a straightforward overview of the medication and its uses. Hosted by Vic Senese, RN, BSN, FAUNACo-host: Laurie Atkinson, RN, FAUNA Subscribe to the UroNurse YouTube channel for more urology education, men's health information, medication discussions, bladder health, prostate health, sexual health and the latest urology news: Subscribe to UroNurse on YouTube Keywords: tadalafil, tadalafil uses, Cialis, Cialis uses, erectile dysfunction, ED treatment, BPH, benign prostatic hyperplasia, enlarged prostate, BPH treatment, urinary symptoms, tadalafil for BPH, tadalafil for ED, pulmonary arterial hypertension, PAH, PDE5 inhibitors, men's health, prostate health, urology, urology nurse, UroNurse, Vic Senese, Laurie Atkinson. The expert's opinions in this communication are personal and not representative of any organization. They are for informational purposes only, not official guidance. Viewers are advised to use their judgment, seek additional advice, and take responsibility for any actions based on these opinions.

  3. Sep 19

    (Audio) Immunotherapy in Bladder Cancer: Practice-Changing Advances Every Urology Professional Should Know

    In this episode of UroNurse, host Vic Senese, RN, BSN, FAUNA, is joined by Matthew Galsky, MD, an internationally recognized expert in genitourinary oncology, to discuss the rapidly evolving role of immunotherapy in bladder cancerand how practice-changing advances are moving from clinical trials into everyday patient care. Bladder cancer treatment has entered a new era. Immune checkpoint inhibitors, antibody-drug conjugates, targeted therapies, and emerging treatment combinations are changing how clinicians approach patients with muscle-invasive bladder cancer (MIBC), metastatic urothelial carcinoma, and advanced bladder cancer. In this conversation, Dr. Galsky discusses important developments in bladder cancer immunotherapy and the implications for urology, oncology, and multidisciplinary patient care. The current role of immunotherapy in bladder cancerHow immune checkpoint inhibitors are changing treatment strategiesThe evolution of treatment for advanced and metastatic urothelial carcinomaPractice-changing clinical trial resultsHow new therapies are being incorporated into clinical practiceImmunotherapy before and after surgeryTreatment considerations for muscle-invasive bladder cancerAdvances in treatment for patients who are not candidates for traditional approachesThe expanding role of combination therapiesAntibody-drug conjugates and their impact on bladder cancer treatmentHow clinicians should think about rapidly emerging treatment optionsThe importance of multidisciplinary collaboration between urology, medical oncology, radiation oncology, and nursingWhat these advances mean for bladder cancer patients and their familiesWhat urology nurses and other healthcare professionals should know about the changing treatment landscapeThe future direction of bladder cancer research and immunotherapyFor decades, treatment options for advanced bladder cancer were relatively limited. Today, clinicians have an increasingly sophisticated range of systemic therapies and treatment combinations. Understanding these developments is particularly important for urology nurses, advanced practice providers, urologists, medical oncologists, and other healthcare professionals who care for patients throughout the bladder cancer journey. This episode provides an educational discussion of the science, clinical evidence, and evolving treatment strategies behind modern bladder cancer immunotherapy. Whether you are a healthcare professional looking to stay current on urothelial carcinoma treatment, a urology nurse following advances in oncology, or a patient seeking to better understand the rapidly changing bladder cancer treatment landscape, this discussion provides valuable perspective from an expert in genitourinary oncology. Hosted by Vic Senese, RN, BSN, FAUNA 🎙️ Guest: Matthew Galsky, MD Subscribe to the UroNurse YouTube channel for more interviews, clinical education, urology news, and discussions with leading experts in urologic healthcare: Subscribe to UroNurse on YouTube The expert's opinions in this communication are personal and not representative of any organization. They are for informational purposes only, not official guidance. Viewers are advised to use their judgment, seek additional advice, and take responsibility for any actions based on these opinions. Topics discussed include:Why this mattersKeywords

  4. Sep 12

    (Audio) Can Prostate Artery Embolization Replace Surgery for BPH?

    Can prostate artery embolization (PAE) provide an effective, minimally invasive treatment option for men with an enlarged prostate? In this episode, Vic Senese, RN, BSN, FAUNA, explores Prostate Artery Embolization (PAE) with Dr. Ayygari, as part of a myCME.com educational series on PAE. PAE is an increasingly important treatment option for men experiencing symptoms caused by benign prostatic hyperplasia (BPH), also known as an enlarged prostate. Unlike traditional prostate surgery, PAE is performed by an interventional radiologist using a catheter to selectively block blood flow to portions of the prostate. The goal is to reduce prostate volume and improve lower urinary tract symptoms (LUTS) associated with BPH. In this episode, we take a closer look at how prostate artery embolization works, how physicians identify the prostate arteries, and where PAE fits among today's treatment options for BPH. What is prostate artery embolization (PAE)?How PAE treats benign prostatic hyperplasia (BPH)How the prostate's blood supply affects the procedureHow physicians identify the prostate arteriesThe role of cone-beam CT during PAEHow embolization particles reduce blood flow to the prostateWhat happens to the prostate after embolizationPotential benefits of PAEPossible risks and complicationsPAE compared with traditional prostate proceduresPAE compared with medications for BPHWho may be an appropriate candidate for PAEWhat patients should ask their urologist and interventional radiologistThe evolving role of PAE in the treatment of LUTS and enlarged prostateProstate Artery Embolization is a minimally invasive procedure designed to reduce blood flow to the prostate. During the procedure, an interventional radiologist guides a small catheter through an artery—often beginning through the wrist or groin—and navigates to the arteries supplying the prostate. Tiny embolic particles are then delivered to selected prostate arteries. By reducing blood flow, the prostate can shrink over time, potentially improving urinary symptoms. One of the fascinating aspects of PAE is that prostate vascular anatomy varies from patient to patient. Advanced imaging, including cone-beam CT, can help physicians identify the appropriate vessels and confirm blood flow during the procedure. 🔎 Topics discussed include:🩺 What is PAE? *The expert's opinions in this communication are personal and not representative of any organization. They are for informational purposes only, not official guidance. Viewers are advised to use their judgment, seek additional advice, and take responsibility for any actions based on these opinions.

  5. Sep 5

    (Audio) How Should You Perform a Voiding Trial? Urology Survey Results May Surprise You!

    Voiding Trial: What’s the BEST Way to Perform It? Survey Says! What is the best way to perform a voiding trial after catheter removal? Should you use the fill-and-pull method, allow the bladder to fill naturally, measure the post-void residual (PVR), or follow another approach? Survey says... there may be more than one way to do it! In this episode, Vic Senese, RN, BSN, FAUNA, explores the important question of how healthcare professionals perform and evaluate a voiding trial, also known as a trial without catheter (TWOC). From bladder filling techniques to determining whether a patient has successfully passed the trial, this episode examines common approaches and the variation that exists in clinical practice. A voiding trial is frequently performed after urinary catheter removal, including following urologic procedures, surgery, episodes of urinary retention, and other situations where clinicians need to determine whether a patient can safely and effectively empty their bladder. 🔹 What a voiding trial or trial without catheter (TWOC) is🔹 Why a voiding trial is performed🔹 The difference between a retrograde fill-and-pull voiding trial and spontaneous bladder filling🔹 How much fluid may be instilled during a bladder-filled voiding trial🔹 What measurements may be used to evaluate successful bladder emptying🔹 The role of voided volume and post-void residual (PVR)🔹 Why there is variation in voiding-trial protocols🔹 Important factors that may influence whether a patient passes or fails a voiding trial🔹 Why standardized protocols can be valuable in clinical practice🔹 What the survey reveals about how healthcare professionals approach voiding trials 👍 LIKE this video if you found the discussion helpful! 🔔 SUBSCRIBE for more urology education:Subscribe to the UroNurse YouTube Channel Hosted by Vic Senese, RN, BSN, FAUNA, bringing practical urology education, clinical discussions, expert insights, and healthcare conversations to urology professionals and others interested in the field. The expert's opinions in this communication are personal and not representative of any organization. They are for informational purposes only, not official guidance. Viewers are advised to use their judgment, seek additional advice, and take responsibility for any actions based on these opinions. In This Episode, You'll Learn:What Is a Voiding Trial?Why Does the Method Matter?

  6. Aug 29

    (Audio) Elevated PSA? Essential Steps Before Ordering a Prostate Biopsy

    An elevated PSA can be alarming—but it doesn't always mean prostate cancer. Before recommending a prostate biopsy, there are several important clinical steps that can improve diagnostic accuracy, reduce unnecessary procedures, and help patients make informed decisions. In this episode of UroNurse, host Vic Senese, RN, BSN, FAUNA, reviews the essential evaluation every clinician should consider after discovering an elevated PSA. Learn how to confirm an abnormal PSA, identify reversible causes of elevation, evaluate patient risk factors, understand the role of PSA density and PSA kinetics, determine when prostate MRI is appropriate, and recognize when additional biomarker testing may help guide clinical decision-making. This evidence-based discussion also explores shared decision-making with patients, current best practices, and practical tips that can help clinicians avoid unnecessary biopsies while identifying patients who may truly benefit from further evaluation. Whether you're a urology nurse, nurse practitioner, physician assistant, primary care provider, resident, medical student, or urologist, this episode provides practical guidance you can apply in everyday clinical practice. Causes of an elevated PSAConfirming an abnormal PSA resultRepeating PSA before biopsyDigital rectal examination (DRE)PSA densityPSA velocity and PSA kineticsRisk factors for prostate cancerFamily history and genetic riskMultiparametric prostate MRIMRI before prostate biopsyBiomarker testing (4Kscore, PHI, ExoDx and others)Active surveillance considerationsShared decision-makingCurrent prostate cancer evaluation guidelinesReducing unnecessary prostate biopsiesBest practices in prostate cancer detectionIf you enjoy evidence-based urology education designed for healthcare professionals, please subscribe to the UroNurse channel and turn on notifications so you never miss our latest episodes. Subscribe here: https://www.youtube.com/@UroNurse1 Hosted and presented by Vic Senese, RN, BSN, FAUNA #Urology #PSA #ProstateCancer #ProstateBiopsy #MRI #ProstateMRI #UroNurse #NursingEducation #UrologyNurse #PrimaryCare #Urologist #ProstateHealth #CancerScreening #4Kscore #PHI #ExoDx #EvidenceBasedMedicine #MedicalEducation #ContinuingEducation #Healthcare The expert's opinions in this communication are personal and not representative of any organization. They are for informational purposes only, not official guidance. Viewers are advised to use their judgment, seek additional advice, and take responsibility for any actions based on these opinions. Topics Covered

  7. Aug 22

    (Audio) Inside UrologyHealth.com: The First Virtual Urology Practice

    Welcome to UroNurse, hosted by Vic Senese, RN, BSN, FAUNA, where healthcare professionals and patients discover the latest innovations transforming urology. In this exclusive interview, Vic is joined by Dr. Diane Newman, Chief Clinical Officer, and Stuart Hart, MD, MBA, MS, Founder & CEO, to introduce UrologyHealth.com—the first virtual urology practice, a groundbreaking digital health platform created by urology experts and backed by more than 50 years of medical science. As healthcare continues to evolve, virtual care is becoming an essential part of delivering accessible, evidence-based medical services. In this conversation, you'll learn how UrologyHealth.com is designed to connect patients with expert urologic care through innovative digital technology while maintaining high clinical standards. What makes UrologyHealth.com the first virtual urology practiceHow telehealth is transforming access to urologic careThe vision behind this innovative digital health platformHow decades of medical science support the platform's clinical approachWhich patients may benefit from virtual urology servicesThe role of technology in improving patient education and outcomesHow virtual care complements traditional office-based urologyFuture trends in digital healthcare and urologyWhether you're a urologist, nurse practitioner, physician assistant, urology nurse, primary care provider, healthcare administrator, or patient interested in the future of medicine, this discussion offers valuable insights into how virtual care is reshaping urology. Don't miss this fascinating conversation with two leaders helping redefine how patients receive specialized urologic care. Featured Guests: Dr. Diane Newman – Chief Clinical OfficerStuart Hart, MD, MBA, MS – Founder & CEOHosted by:Vic Senese, RN, BSN, FAUNA If you enjoy interviews featuring the latest innovations in urology, healthcare technology, and patient care: ✅ Like this video✅ Subscribe for weekly urology news and expert interviews✅ Share this video with your colleagues✅ Leave your questions and comments below Subscribe to my channel:https://www.youtube.com/@UroNurse1 #Urology #Telehealth #VirtualCare #DigitalHealth #UrologyHealth #UroNurse #VicSenese #DianeNewman #StuartHart #HealthcareInnovation #UrologyNursing #PatientCare #MedicalTechnology #Telemedicine #HealthcareLeadership #FutureOfHealthcare #UrologyEducation #NursingEducation #MedicalPodcast #HealthcareTechnology The expert's opinions in this communication are personal and not representative of any organization. They are for informational purposes only, not official guidance. Viewers are advised to use their judgment, seek additional advice, and take responsibility for any actions based on these opinions. In this episode you'll discover:

  8. Aug 15

    (Audio) Genital Psoriasis Explained: Improving Patient Care

    Genital psoriasis is a common yet frequently underdiagnosed condition that can significantly affect a patient's physical comfort, emotional well-being, intimate relationships, and overall quality of life. Because many patients feel embarrassed to discuss symptoms, healthcare professionals must proactively recognize, assess, and manage this challenging condition with compassion and confidence. Join host Vic Senese, RN, BSN, FAUNA, for an engaging educational discussion featuring renowned dermatology experts David Cotter, MD and Naiem Issa, MD. Together, they explore the latest evidence-based approaches to diagnosing and treating genital psoriasis while emphasizing patient-centered communication and individualized care. *The expert's opinions in this communication are personal and not representative of any organization. They are for informational purposes only, not official guidance. Viewers are advised to use their judgment, seek additional advice, and take responsibility for any actions based on these opinions.

See All (216)

Ratings & Reviews

5
out of 5
6 Ratings

About

UroNurse is a one hour podcast connecting healthcare workers to urology expert panelists. You can check out our videos and live webinars at uronurse.com. Our podcasts provide an audio copy for you to enjoy in your car or wherever.

Information

  • Creator
    UroNurse
  • Years Active
    2023 - 2026
  • Episodes
    216
  • Rating
    Explicit
  • Copyright
    © UroNurse
  • Show Website
    UroNurse

You Might Also Like